Inventiva (IVA) Revenue (2020 - 2022)

Inventiva (IVA) recorded quarterly Revenue of $3.9 million in Q4 2022, up 4847.59% quarter-over-quarter from $78277.6 in Q2 2021.

Inventiva (IVA) Revenue (2020 - 2022) Analysis & Trends

Inventiva's Revenue history runs 3 years deep, the most recent figure standing at $3.9 million for Q4 2022.

  • In Q4 2022, Revenue changed N/A year-over-year to $3.9 million; the TTM figure through Dec 2022 stood at $4.1 million (changed N/A YoY), while the FY2025 annual figure was $5.2 million, down 46.91% from the prior year.
  • Revenue was $3.9 million for Q4 2022 at Inventiva, up from $78277.6 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $3.9 million in Q4 2022 to a low of $78277.6 in Q2 2021.
  • Historically, Revenue has averaged $843589.8 across 3 years, with a median of $89261.5 in 2021.
  • Biggest YoY gain for Revenue was 3.96% in 2021; the steepest drop was 7.06% in 2021.
  • A 3-year view of Revenue shows it stood at $81508.0 in 2020, then slipped by 3.96% to $78277.6 in 2021, then soared by 4847.59% to $3.9 million in 2022.
  • The last three Revenue figures came in at $3.9 million (Q4 2022), $78277.6 (Q2 2021), and $89261.5 (Q1 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 5.21 Mn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 306.30 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 2.99 Bn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Inventiva 8.78 Mn -259.95 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 3.87 Mn
Jun 30, 2021 78,277.64
Mar 31, 2021 89,261.47
Jun 30, 2020 81,508.05
Mar 31, 2020 96,042.70